arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

NATURAL ALTERNATIVES INTERNATIONAL INC

NAII
$1.12 ▲ +0.05 (+4.67%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
65 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

NATURAL ALTERNATIVES INTERNATIONAL INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC -26.5% ↘
FCF / Share None
Trailing P/E —
Price / Book 0.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$35.48M
↑ +23.3% —
Net Income Profit after all expenses
$-13.54M
↓ -87.6% —
Operating Margin Operating profit as % of sales
-11.3%
↓ -113.1% 9th
FCF / Share Free cash flow per share
$0.23
↑ +119.3% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability →
8
Returns
17
Financial Health
27
Cash Quality
43

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 65 quarters